ResMed
As on 02 Jul, 2025 | 01:29 IST
| Open | 257.22 |
| Previous Close | 258.00 |
| Beta | 0.31 |
| High | 258.16 |
| Low | 254.88 |
| TTM EPS See historical trend | 9.08(+25.24% YoY) |
| 52 Week High | 262.96 |
| 52 Week Low | 196.50 |
| TTM PE See historical trend | 28.22(Low PE) |
| Mkt. Cap ($ Billion) | 37.69 |
| Dividend Yield | 0.95 |
Advanced Chart
*Delayed by 20 seconds.
MC Technicals
| Days | |
|---|---|
| 5 | 256.74 |
| 10 | 254.89 |
| 20 | 252.74 |
| 50 | 244.96 |
| 100 | 235.54 |
| 200 | 238.53 |
Returns
| 1 Week | -0.60% | |
| 1 Month | 2.50% | |
| 3 Months | 20.34% | |
| YTD | 11.97% | |
| 1 Year | 24.35% | |
| 3 Years | 13.64% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 484.75 | 4.92 | 184.84 | 22.15 | 21.89 | 0.41 | 618.22/385.72 | -1.68 | Very Bullish |
| Intuitive Surgical | 447.18 | 1.81 | 158.50 | 55.55 | 8.05 | -- | 614.58/429.72 | -5.55 | Very Bearish |
| Medtronic | 95.08 | 1.16 | 115.08 | 21.40 | 4.45 | 3.02 | 96.17/79.31 | 2.70 | Bullish |
| Edwards Lifesciences | 77.80 | 0.79 | 45.53 | 29.69 | 2.60 | -- | 95.25/58.97 | -1.22 | Very Bullish |
| ResMed | 273.73 | 0.99 | 37.69 | 28.22 | 9.08 | 0.95 | 262.96/196.50 | 2.50 | Very Bullish |
Market news
- Stocks finish week higher; Wall Street at record highsSeptember 20, 2025 7:43 AM
- Nasdaq notches record high close, traders look to Fed meetingSeptember 13, 2025 9:16 AM
- Wall Street indexes end lower as jobs data fuels economic worriesSeptember 6, 2025 10:13 AM
- S&P 500 ends lower as Dell and Nvidia dropAugust 30, 2025 10:46 AM
About the company
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.